Shandong Hualu-Hengsheng Chemical (600426) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Q1 2025 revenue was RMB 7.77 billion, down 2.59% year-over-year; net profit attributable to shareholders was RMB 707 million, down 33.65% year-over-year.
Decline in profit mainly due to lower product prices during the period.
Financial highlights
Operating cash flow for Q1 was RMB 930 million, down 17.72% year-over-year.
Basic and diluted EPS were both RMB 0.334, down 33.47% year-over-year.
Total assets at quarter-end were RMB 48.07 billion, up 3.02% from year-end 2024.
Net assets attributable to shareholders reached RMB 31.74 billion, up 2.31% from year-end 2024.
Key financial ratios and metrics
Weighted average ROE for Q1 was 2.25%, down 1.37 percentage points year-over-year.
Gross margin declined as operating costs rose to RMB 6.87 billion from RMB 6.57 billion year-over-year.
Latest events from Shandong Hualu-Hengsheng Chemical
- Revenue and net profit grew strongly year-over-year, with robust cash flow and high R&D investment.600426
H2 202419 Dec 2025 - Net profit fell 29.5% on lower prices, but core market share and project progress remained strong.600426
H1 202518 Dec 2025 - Q3 2025 net profit declined 2.38% year-over-year as revenue and margins fell.600426
Q3 202530 Oct 2025 - Revenue up, but Q3 profit dropped sharply on lower prices and maintenance.600426
Q3 202413 Jun 2025 - Revenue and net profit surged over 30% year-over-year, with robust cash flow and dividend payout.600426
H1 202413 Jun 2025